| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.501 | 12.772 | 14.796 | 11.418 | 15.855 | 24.276 | 18.000 | 24.145 | 48.855 | 51.569 |
| Total Income - EUR | 15.139 | 13.467 | 15.602 | 11.418 | 15.855 | 24.276 | 18.021 | 24.145 | 48.874 | 51.624 |
| Total Expenses - EUR | 16.212 | 6.791 | 5.581 | 3.762 | 8.357 | 11.933 | 8.012 | 12.366 | 35.452 | 42.174 |
| Gross Profit/Loss - EUR | -1.073 | 6.676 | 10.021 | 7.656 | 7.497 | 12.343 | 10.009 | 11.779 | 13.422 | 9.451 |
| Net Profit/Loss - EUR | -1.527 | 6.272 | 9.553 | 7.374 | 7.021 | 11.615 | 9.532 | 11.305 | 12.951 | 8.961 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Tiens Biolife Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.124 | 8.313 | 7.760 | 7.618 | 3.886 | 3.633 | 1.386 | 8.876 | 8.223 | 7.238 |
| Current Assets | 1.190 | 3.536 | 9.818 | 16.017 | 26.490 | 38.298 | 44.762 | 48.785 | 31.338 | 32.697 |
| Inventories | 432 | 963 | 1.668 | 1.360 | 1.334 | 508 | 670 | 1.874 | 3.767 | 1.541 |
| Receivables | 0 | 0 | 709 | 1.986 | 3.107 | 3.529 | 6.771 | 2.573 | 25.387 | 21.583 |
| Cash | 758 | 2.573 | 7.441 | 12.671 | 22.049 | 34.262 | 37.320 | 44.338 | 2.184 | 9.573 |
| Shareholders Funds | 8.762 | 6.326 | 15.772 | 22.856 | 29.434 | 40.491 | 44.869 | 56.313 | 37.455 | 37.073 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 735 | 5.035 | 1.300 | 845 | 973 | 1.470 | 1.321 | 1.565 | 2.292 | 2.974 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6832 - 6832" | |||||||||
| CAEN Financial Year |
6832
|
|||||||||
Comments - Tiens Biolife Srl